Weight Stuck on Mounjaro: Why It Happens and What to Do

What the trial data tell us about plateaus

The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults with obesity over 72 weeks. Average weight loss at the 15mg dose reached around 20–21%, but that figure masks something important: progress was not linear. Weight curves in the trial flattened periodically before resuming. The plateau you are experiencing has a parallel in the very evidence base that supports this treatment.

The biological reason is your body's adaptive metabolism. As you lose weight, your resting energy needs fall and certain hormonal signals push back against further loss. Mounjaro works against those signals, but it does not override them indefinitely at any one dose. This is partly why the licensed schedule starts at 2.5mg and titrates upward, each increase re-engages appetite suppression at a level your system has not yet adapted to. If your weight has stalled, the prescriber question is whether your current dose still has room to work, or whether other factors are limiting it.

One quick check worth doing right now: look at your meal sizes over the past two weeks compared with when you started. Appetite suppression often eases slightly between dose increases, and portion sizes can creep back up almost imperceptibly. That one-minute observation has told many people on this medicine exactly where their plateau came from.

Common reasons weight stalls on Mounjaro, beyond the dose

A plateau does not always mean the medicine needs changing. Several other factors reliably interrupt progress and are worth examining honestly before your next prescriber conversation.

Protein intake is one of the most consistent. Mounjaro significantly reduces appetite, which makes it easy to eat less of everything, including protein. Inadequate protein slows the retention of muscle mass during weight loss, and less muscle mass lowers your baseline calorie burn. Aiming to keep protein adequate at each meal matters more, not less, when your overall intake has fallen. The NHS healthy weight guidance covers the basics of balanced eating alongside weight management.

Sleep and stress are frequently overlooked. Poor sleep raises ghrelin (a hunger-driving hormone) and cortisol, both of which work against tirzepatide's appetite-suppressing effects. If sleep quality has dropped, that is worth mentioning in your next review.

Physical activity also shifts in ways people do not always notice. Early in treatment, energy tends to rise and movement increases naturally. A few months in, routine can drift back. Strength-based activity in particular helps preserve muscle during active weight loss, something that matters for how your body is changing even when the scale is not.

Finally, fluid intake. Mounjaro slows gastric emptying, and some people quietly under-drink across the day. Dehydration affects energy, perceived hunger signals and (in some cases) the number on the scale itself.

When to bring a prescriber into the conversation

A stall of two to three weeks after a dose stabilisation is worth noting but not usually alarming. A plateau persisting for four to six weeks, particularly if diet and activity have not changed, is the right moment to contact your clinical team. Dose titration decisions sit firmly with your prescriber, trying to self-manage by adjusting timing or increasing injection frequency is not safe and is not what the licensed schedule supports.

There are also physiological reasons a prescriber might want to rule out. Thyroid function, blood glucose patterns and certain medications can independently blunt weight-loss progress. A brief clinical review can separate those causes from a straightforward adaptive plateau. If you're on a lower dose and have not yet reached your maintenance level, the answer may simply be to move to the next step in the titration schedule when clinically appropriate.

It is also worth looking at how Mounjaro produces weight loss in more detail, so you have a realistic picture of what different phases of treatment typically look like. And if weight has recently increased rather than stalled, the causes of weight gain on Mounjaro are a separate but related topic worth reading.

For a fuller picture of the realistic outcomes people experience across the treatment programme, our guide to Mounjaro weight pulls together the evidence on timelines and what shapes individual results. And if cost or access is part of the picture (for example, if you are wondering whether staying at a lower dose for longer to manage Mounjaro's cost is affecting your results) that is worth raising openly with your prescriber too.

Practical steps to discuss at your next clinical review

Going into a review with some structure helps. Consider keeping a brief note over the week before your appointment covering: how your appetite has felt day to day, whether your meal sizes or composition have shifted, your sleep quality and your activity level. None of this is about self-diagnosing; it is about giving your prescriber the information they need to make a useful recommendation.

Your prescriber may also want to know how long you have been at your current dose, whether any new medicines have been added recently, and whether your weight-related health markers (blood pressure, blood glucose if relevant) have continued improving even while the scale has not moved. Weight is one measure. It is not always the only one that matters clinically at a given point in treatment.

The NICE appraisal of tirzepatide (TA1026) sets out the clinical framework for reviewing progress, including that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment is reassessed. That threshold is a guideline for clinical review, not a verdict. Context matters, and the review itself is the point. If you have questions about your treatment or want practical guidance on how to lose weight on Mounjaro more effectively, speaking to our prescribers is a straightforward next step, and our dedicated page on losing weight on Mounjaro is a useful place to start before that conversation.